haloperidol has been researched along with Heart Failure in 7 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol is an antipsychotic drug that inhibits the dopamine D2 receptor among others." | 5.43 | Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction. ( Bhuiyan, MS; Fukunaga, K; Hasegawa, H; Kanai, H; Shinoda, Y; Tagashira, H, 2016) |
| "Haloperidol is an antipsychotic drug that inhibits the dopamine D2 receptor among others." | 1.43 | Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction. ( Bhuiyan, MS; Fukunaga, K; Hasegawa, H; Kanai, H; Shinoda, Y; Tagashira, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Shinoda, Y | 1 |
| Tagashira, H | 1 |
| Bhuiyan, MS | 1 |
| Hasegawa, H | 1 |
| Kanai, H | 1 |
| Fukunaga, K | 1 |
| Hewer, W | 1 |
| Kauder, E | 1 |
| Vierling, P | 1 |
| Vural, A | 1 |
| Tezer, FI | 1 |
| LEONE, BN | 1 |
| Iwahashi, K | 1 |
| Keshavarz-Bahaghighat, H | 1 |
| Darwesh, AM | 1 |
| Sosnowski, DK | 1 |
| Seubert, JM | 1 |
| Kirsch, UE | 1 |
| Nasseri, M | 1 |
| Bücherl, ES | 1 |
1 review available for haloperidol and Heart Failure
| Article | Year |
|---|---|
Mitochondrial Dysfunction and Inflammaging in Heart Failure: Novel Roles of CYP-Derived Epoxylipids.
Topics: Animals; Cardiovascular Diseases; Epoxy Resins; Fatty Acids, Unsaturated; Heart Failure; Humans; Imm | 2020 |
6 other studies available for haloperidol and Heart Failure
| Article | Year |
|---|---|
Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antipsychotic Agents; Aorta; Calcium; Constriction; | 2016 |
Fatal pulmonary embolism following antipsychotic treatment and physical restraint.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Fatal Outcome; Female; Haloperidol; Heart Arrest; Heart | 2009 |
Myoclonus induced by haloperidol in the intensive care unit.
Topics: Aged, 80 and over; Dopamine Antagonists; Dyspnea; Electroencephalography; Haloperidol; Heart Failure | 2012 |
[ON PSYCHOSES INDUCED BY CARDIAC DECOMPENSATION. THERAPEUTIC FINDINGS AND NOTES].
Topics: Haloperidol; Heart Failure; Humans; Mental Disorders; Psychotic Disorders | 1963 |
Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Electr | 1996 |
Left ventricular bypass in experimental left heart failure.
Topics: Animals; Assisted Circulation; Blood Pressure; Dogs; Electrocardiography; Epoxy Resins; Fluorocarbon | 1966 |